Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.61% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
UTMD · Sep 30, 2021
UTAH MEDICAL PRODUCTS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001811884-21-000016General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
47.65% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
19.97% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
50.10% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
64.21% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
40.55% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.01% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
0.33% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History29 statesSelf-history eligible
Dec 31, 20217/9 normalizedLevel 3Mar 31, 20227/8 normalizedLevel 3Jun 30, 20227/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/9 normalizedLevel 3Dec 31, 20228/9 normalizedAmended as filedMar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/9 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/9 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/9 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 1.68%
- Current
- 0.61%
- Delta
- -1.07%
- Previous
- 37.23%
- Current
- 47.65%
- Delta
- 10.43%
- Previous
- 43.44%
- Current
- 19.97%
- Delta
- -23.47%
- Previous
- 48.54%
- Current
- 50.10%
- Delta
- 1.56%
- Previous
- 61.77%
- Current
- 64.21%
- Delta
- 2.45%
- Previous
- 37.81%
- Current
- 40.55%
- Delta
- 2.75%
- Previous
- 1.02%
- Current
- 1.01%
- Delta
- -0.01%
- Previous
- 0.33%
- Current
- 0.33%
- Delta
- 0.00%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · UTMD Fundamental State →Has State · UTAH MEDICAL PRODUCTS INC →Transitioned To · UTMD Fundamental State →Transitioned To · UTMD CAPEX_INTENSITY_DECREASED →Transitioned To · UTMD CASH_GENERATION_INCREASED →Transitioned To · UTMD GROWTH_DECREASED →Transitioned To · UTMD INVENTORY_PRESSURE_INCREASED →Transitioned To · UTMD MARGIN_INCREASED →Transitioned To · UTMD PROFITABILITY_INCREASED →Transitioned To · UTMD R_AND_D_INTENSITY_DECREASED →Transitioned To · UTMD SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.